Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Hanlon

Showing results (21-30 of 90) with videos related to

Pageof 9
Sort By:
BMC Medicine|January 28, 2026
Eligibility of real-world patients for aspirin primary prevention trials in cardiovascular diseaseMichael Holder, Daniel R Morales, Peter Hanlon, et al.
The Lancet. Healthy Longevity|August 24, 2025
Applicability of the electronic frailty index in younger and older adults in England: a population-based cohort studyDaniel R Morales, Bruce Guthrie, Thomas J Downes, et al.
NPJ Primary Care Respiratory Medicine|January 5, 2023
Systematic review and meta-analysis of prevalence, trajectories, and clinical outcomes for frailty in COPDPeter Hanlon, Xuetong Guo, Eveline McGhee, et al.
BMC Medicine|October 22, 2020
Identifying frailty in trials: an analysis of individual participant data from trials of novel pharmacological interventionsPeter Hanlon, Elaine Butterly, Jim Lewsey, et al.
Annals of Family Medicine|March 21, 2023
Representativeness of antihypertensive trials: analysis of serious adverse eventsPeter Hanlon, Anoop Shah, Frances Mair, et al.
BMC Medical Informatics and Decision Making|September 16, 2016
Understanding factors affecting patient and public engagement and recruitment to digital health interventions: a systematic review of qualitative studiesSiobhan O'Connor, Peter Hanlon, Catherine A O'Donnell, et al.
BMJ Open|September 4, 2016
Barriers and facilitators to patient and public engagement and recruitment to digital health interventions: protocol of a systematic review of qualitative studiesSiobhan O'Connor, Peter Hanlon, Catherine A O'Donnell, et al.
Journal of Comorbidity|August 27, 2020
Association between childhood maltreatment and the prevalence and complexity of multimorbidity: A cross-sectional analysis of 157,357 UK Biobank participantsPeter Hanlon, Marianne McCallum, Bhautesh Dinesh Jani, et al.
The Lancet. Public Health|June 18, 2018
Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank participantsPeter Hanlon, Barbara I Nicholl, Bhautesh Dinesh Jani, et al.
The Lancet. Healthy Longevity|December 14, 2020
Frailty measurement, prevalence, incidence, and clinical implications in people with diabetes: a systematic review and study-level meta-analysisPeter Hanlon, Isabella Fauré, Neave Corcoran, et al.
Pageof 9

Showing results (21-30 of 90) with videos related to

Sort By:
Pageof 9
BMC Medicine|January 28, 2026
Eligibility of real-world patients for aspirin primary prevention trials in cardiovascular diseaseMichael Holder, Daniel R Morales, Peter Hanlon, et al.
The Lancet. Healthy Longevity|August 24, 2025
Applicability of the electronic frailty index in younger and older adults in England: a population-based cohort studyDaniel R Morales, Bruce Guthrie, Thomas J Downes, et al.
NPJ Primary Care Respiratory Medicine|January 5, 2023
Systematic review and meta-analysis of prevalence, trajectories, and clinical outcomes for frailty in COPDPeter Hanlon, Xuetong Guo, Eveline McGhee, et al.
BMC Medicine|October 22, 2020
Identifying frailty in trials: an analysis of individual participant data from trials of novel pharmacological interventionsPeter Hanlon, Elaine Butterly, Jim Lewsey, et al.
Annals of Family Medicine|March 21, 2023
Representativeness of antihypertensive trials: analysis of serious adverse eventsPeter Hanlon, Anoop Shah, Frances Mair, et al.
BMC Medical Informatics and Decision Making|September 16, 2016
Understanding factors affecting patient and public engagement and recruitment to digital health interventions: a systematic review of qualitative studiesSiobhan O'Connor, Peter Hanlon, Catherine A O'Donnell, et al.
BMJ Open|September 4, 2016
Barriers and facilitators to patient and public engagement and recruitment to digital health interventions: protocol of a systematic review of qualitative studiesSiobhan O'Connor, Peter Hanlon, Catherine A O'Donnell, et al.
Journal of Comorbidity|August 27, 2020
Association between childhood maltreatment and the prevalence and complexity of multimorbidity: A cross-sectional analysis of 157,357 UK Biobank participantsPeter Hanlon, Marianne McCallum, Bhautesh Dinesh Jani, et al.
The Lancet. Public Health|June 18, 2018
Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank participantsPeter Hanlon, Barbara I Nicholl, Bhautesh Dinesh Jani, et al.
The Lancet. Healthy Longevity|December 14, 2020
Frailty measurement, prevalence, incidence, and clinical implications in people with diabetes: a systematic review and study-level meta-analysisPeter Hanlon, Isabella Fauré, Neave Corcoran, et al.
Pageof 9